| ■ 영문 제목 : Global mRNA Cancer Vaccines and Therapeutics Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02233 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 105 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 mRNA 암 백신 및 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (선암, 점액성암, 선편평상피암)와 용도별 시장규모 (감염증, 암, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 mRNA 암 백신 및 치료제 시장 점유율 - 지역별 mRNA 암 백신 및 치료제 시장규모 - 주요지역의 종류별 시장규모 (선암, 점액성암, 선편평상피암) - 주요지역의 용도별 시장규모 (감염증, 암, 기타) - 미주의 mRNA 암 백신 및 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 mRNA 암 백신 및 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 mRNA 암 백신 및 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 mRNA 암 백신 및 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 mRNA 암 백신 및 치료제 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology - 조사의 결과/결론 |
According to this latest study, the 2021 growth of mRNA Cancer Vaccines and Therapeutics will have significant change from previous year. By the most conservative estimates of global mRNA Cancer Vaccines and Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 111.9 million in 2020. Over the next five years the mRNA Cancer Vaccines and Therapeutics market will register a 19.7% CAGR in terms of revenue, the global market size will reach US$ 229.7 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Cancer Vaccines and Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Infectious Disease
Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
1 Scope of the Report 2 Executive Summary 3 mRNA Cancer Vaccines and Therapeutics Market Size by Players 4 mRNA Cancer Vaccines and Therapeutics by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global mRNA Cancer Vaccines and Therapeutics Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. mRNA Cancer Vaccines and Therapeutics Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Adeno Carcinomas Table 3. Major Players of Mucinous Carcinomas Table 4. Major Players of Adenosquamous Carcinomas Table 5. mRNA Cancer Vaccines and Therapeutics Market Size CAGR by Type (2020-2026) & ($ Millions) Table 6. Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 7. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2016-2021) Table 8. mRNA Cancer Vaccines and Therapeutics Market Size CAGR by Application (2016-2021) & ($ Millions) Table 9. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 10. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2016-2021) Table 11. Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2019-2021E) & ($ Millions) Table 12. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2019-2021E) Table 13. mRNA Cancer Vaccines and Therapeutics Key Players Head office and Products Offered Table 14. mRNA Cancer Vaccines and Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global mRNA Cancer Vaccines and Therapeutics Market Size by Regions 2016-2021 & ($ Millions) Table 18. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Regions 2016-2021 Table 19. Americas mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021) & ($ Millions) Table 20. Americas mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Country (2016-2021) Table 21. Americas mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 22. Americas mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2016-2021) Table 23. Americas mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 24. Americas mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2016-2021) Table 25. APAC mRNA Cancer Vaccines and Therapeutics Market Size by Region (2016-2021) & ($ Millions) Table 26. APAC mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Region (2016-2021) Table 27. APAC mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 28. APAC mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2016-2021) Table 29. APAC mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 30. APAC mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2016-2021) Table 31. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2016-2021) & ($ Millions) Table 32. Europe mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Country (2016-2021) Table 33. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 34. Europe mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2016-2021) Table 35. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 36. Europe mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2016-2021) Table 37. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Region (2016-2021) & ($ Millions) Table 38. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Region (2016-2021) Table 39. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 40. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2016-2021) Table 41. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 42. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2016-2021) Table 43. Key and Potential Regions of mRNA Cancer Vaccines and Therapeutics Table 44. Key Application and Potential Industries of mRNA Cancer Vaccines and Therapeutics Table 45. Key Challenges of mRNA Cancer Vaccines and Therapeutics Table 46. Key Trends of mRNA Cancer Vaccines and Therapeutics Table 47. Global mRNA Cancer Vaccines and Therapeutics Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 48. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share Forecast by Regions (2021-2026) Table 49. Global mRNA Cancer Vaccines and Therapeutics Market Size Forecast by Type (2021-2026) & ($ Millions) Table 50. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share Forecast by Type (2021-2026) Table 51. Global mRNA Cancer Vaccines and Therapeutics Market Size Forecast by Application (2021-2026) & ($ Millions) Table 52. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share Forecast by Application (2021-2026) Table 53. Moderna Therapeutics Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors Table 54. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offered Table 55. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 56. Moderna Therapeutics Main Business Table 57. Moderna Therapeutics Latest Developments Table 58. CureVac Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors Table 59. CureVac mRNA Cancer Vaccines and Therapeutics Product Offered Table 60. CureVac Main Business Table 61. CureVac mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 62. CureVac Latest Developments Table 63. Translate Bio Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors Table 64. Translate Bio mRNA Cancer Vaccines and Therapeutics Product Offered Table 65. Translate Bio Main Business Table 66. Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 67. Translate Bio Latest Developments Table 68. BioNTech Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors Table 69. BioNTech mRNA Cancer Vaccines and Therapeutics Product Offered Table 70. BioNTech Main Business Table 71. BioNTech mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 72. BioNTech Latest Developments Table 73. Sangamo Therapeutics Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors Table 74. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offered Table 75. Sangamo Therapeutics Main Business Table 76. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 77. Sangamo Therapeutics Latest Developments Table 78. Argos Therapeutics Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors Table 79. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offered Table 80. Argos Therapeutics Main Business Table 81. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 82. Argos Therapeutics Latest Developments Table 83. In-Cell-Art Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors Table 84. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product Offered Table 85. In-Cell-Art Main Business Table 86. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 87. In-Cell-Art Latest Developments Table 88. eTheRNA Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors Table 89. eTheRNA mRNA Cancer Vaccines and Therapeutics Product Offered Table 90. eTheRNA Main Business Table 91. eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 92. eTheRNA Latest Developments Table 93. Ethris Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors Table 94. Ethris mRNA Cancer Vaccines and Therapeutics Product Offered Table 95. Ethris Main Business Table 96. Ethris mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 97. Ethris Latest Developments Table 98. Tiba Biotechnology Details, Company Type, mRNA Cancer Vaccines and Therapeutics Area Served and Its Competitors Table 99. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product Offered Table 100. Tiba Biotechnology Main Business Table 101. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 102. Tiba Biotechnology Latest Developments List of Figures Figure 1. mRNA Cancer Vaccines and Therapeutics Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type in 2020 Figure 7. mRNA Cancer Vaccines and Therapeutics in Infectious Disease Figure 8. Global mRNA Cancer Vaccines and Therapeutics Market: Infectious Disease (2016-2021) & ($ Millions) Figure 9. mRNA Cancer Vaccines and Therapeutics in Cancer Figure 10. Global mRNA Cancer Vaccines and Therapeutics Market: Cancer (2016-2021) & ($ Millions) Figure 11. mRNA Cancer Vaccines and Therapeutics in Others Figure 12. Global mRNA Cancer Vaccines and Therapeutics Market: Others (2016-2021) & ($ Millions) Figure 13. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application in 2020 Figure 14. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Player in 2020 Figure 15. Global mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Regions (2016-2021) Figure 16. Americas mRNA Cancer Vaccines and Therapeutics Market Size 2016-2021 ($ Millions) Figure 17. APAC mRNA Cancer Vaccines and Therapeutics Market Size 2016-2021 ($ Millions) Figure 18. Europe mRNA Cancer Vaccines and Therapeutics Market Size 2016-2021 ($ Millions) Figure 19. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size 2016-2021 ($ Millions) Figure 20. Americas mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Country in 2020 Figure 21. Americas mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type in 2020 Figure 22. Americas mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application in 2020 Figure 23. United States mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 24. Canada mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 25. Mexico mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 26. APAC mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Regions in 2020 Figure 27. APAC mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type in 2020 Figure 28. APAC mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application in 2020 Figure 29. China mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 30. Japan mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 31. Korea mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 32. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 33. India mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 34. Australia mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 35. Europe mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Country in 2020 Figure 36. Europe mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type in 2020 Figure 37. Europe mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application in 2020 Figure 38. Germany mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 39. France mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 40. UK mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 41. Italy mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 42. Russia mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 43. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Region in 2020 Figure 44. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type in 2020 Figure 45. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application in 2020 Figure 46. Egypt mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 47. South Africa mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 48. Israel mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 49. Turkey mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 50. GCC Country mRNA Cancer Vaccines and Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 51. Americas mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 52. APAC mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 53. Europe mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 54. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 55. United States mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 56. Canada mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 57. Mexico mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 58. Brazil mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 59. China mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 60. Japan mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 61. Korea mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 62. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 63. India mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 64. Australia mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 65. Germany mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 66. France mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 67. UK mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 68. Italy mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 69. Russia mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 70. Spain mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 71. Egypt mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 72. South Africa mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 73. Israel mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 74. Turkey mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) Figure 75. GCC Country mRNA Cancer Vaccines and Therapeutics Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 mRNA 암 백신 및 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K02233) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 mRNA 암 백신 및 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |